AbbVie

ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.575%

12M weight contribution

-0.296 pp

3M weight contribution

-0.328 pp

12M price return

+8.5%

Share of matched S&P 500 members

Monthly observations through Jul 2023

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Jul 2023	$263.9bn	0.575%	-0.296 pp	+8.5%	No
Jun 2023	$237.7bn	0.550%	-0.503 pp	-8.6%	No
May 2023	$243.4bn	0.601%	-0.337 pp	-2.8%	No
Apr 2023	$267.4bn	0.903%	-0.036 pp	+6.9%	No
Mar 2023	$282.0bn	0.962%	-0.003 pp	+2.1%	Yes
Feb 2023	$272.3bn	0.957%	+0.051 pp	+8.1%	Yes
Jan 2023	$261.3bn	0.894%	+0.080 pp	+12.0%	No
Dec 2022	$285.8bn	1.031%	+0.265 pp	+24.0%	Yes
Nov 2022	$285.0bn	0.967%	+0.279 pp	+45.3%	Yes
Oct 2022	$258.8bn	0.919%	+0.242 pp	+32.6%	No
Sep 2022	$237.3bn	0.933%	+0.263 pp	+29.5%	Yes
Aug 2022	$237.7bn	0.851%	+0.137 pp	+15.9%	No
Jul 2022	$253.6bn	0.871%	+0.167 pp	+28.5%	No
Jun 2022	$270.7bn	1.053%	+0.350 pp	+41.8%	Yes
May 2022	$260.4bn	0.938%	+0.222 pp	+35.8%	Yes
Apr 2022	$259.8bn	0.939%	+0.226 pp	+37.4%	Yes
Mar 2022	$286.7bn	0.965%	+0.591 pp	+56.8%	Yes
Feb 2022	$261.4bn	0.907%	+0.526 pp	+43.5%	Yes
Jan 2022	$242.0bn	0.814%	+0.381 pp	+39.8%	Yes
Dec 2021	$239.4bn	0.767%	+0.001 pp	+32.4%	Yes
Nov 2021	$203.8bn	0.689%	-0.096 pp	+15.5%	No
Oct 2021	$202.6bn	0.677%	-0.034 pp	+41.2%	No
Sep 2021	$190.6bn	0.669%	+0.669 pp	+29.3%	No
Aug 2021	$213.4bn	0.714%	+0.713 pp	+32.4%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.